These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24096604)

  • 21. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K; Heine J; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
    McTier TL; Six RH; Pullins A; Chapin S; Kryda K; Mahabir SP; Woods DJ; Maeder SJ
    Parasit Vectors; 2019 Sep; 12(1):444. PubMed ID: 31506088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental Dirofilaria immitis infection in dogs: effects of doxycycline and Advantage Multi® administration on immature adult parasites.
    Chandrashekar R; Beall MJ; Saucier J; O'Connor T; McCall JW; McCall SD
    Vet Parasitol; 2014 Nov; 206(1-2):93-8. PubMed ID: 25218886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid.
    Huang HP; Lien YH
    Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%.
    Bianciardi P; Otranto D
    Vet Parasitol; 2005 Apr; 129(1-2):89-93. PubMed ID: 15817208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition and prevention efficacy against mosquito bloodsucking and Dirofilaria immitis infection by administration of topical insecticide.
    Hayasaki M; Saeki H
    J Vet Med Sci; 2009 Aug; 71(8):1049-52. PubMed ID: 19721356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi
    Bowman DD; Ohmes CM; Hostetler JA; Keil DJ; Settje TL; Charles SD
    Parasit Vectors; 2017 Nov; 10(Suppl 2):478. PubMed ID: 29143660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imidacloprid/moxidectin topical solution for the prevention of heartworm disease and the treatment and control of flea and intestinal nematodes of cats.
    Arther RG; Charles S; Ciszewski DK; Davis WL; Settje TS
    Vet Parasitol; 2005 Oct; 133(2-3):219-25. PubMed ID: 16198823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs.
    Loft KE; Willesen JL
    Vet Rec; 2007 Apr; 160(15):528-9. PubMed ID: 17435103
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs.
    McCall JW; Arther R; Davis W; Settje T
    Vet Parasitol; 2014 Nov; 206(1-2):86-92. PubMed ID: 25444277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of imidacloprid plus moxidectin topical solution applied to cats heavily infected with adult heartworms (Dirofilaria immitis).
    Arther RG; Atkins C; Ciszewski DK; Davis WL; Ensley SM; Settje TL
    Parasitol Res; 2005 Oct; 97 Suppl 1():S70-S75. PubMed ID: 16228278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.
    Genchi C; Genchi M; Petry G; Kruedewagen EM; Schaper R
    Parasitol Res; 2013 Aug; 112 Suppl 1():81-9. PubMed ID: 23774842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
    Heine J; Krieger K; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
    Colombo S; Leone F; Vercelli A; Cornegliani L
    Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Field efficacy and safety of a combination of moxidectin and imidacloprid for the prevention of feline heartworm (Dirofilaria immitis) infection.
    Venco L; Mortarino M; Carro C; Genchi M; Pampurini F; Genchi C
    Vet Parasitol; 2008 Jun; 154(1-2):67-70. PubMed ID: 18395348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
    Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs.
    Bowman DD; Grazette AR; Basel C; Wang Y; Hostetler JA
    Parasit Vectors; 2016 Jan; 9():12. PubMed ID: 26746229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subconjunctival Dirofilaria repens infection in a dog resident in the UK.
    Agapito D; Aziz NA; Wang T; Morgan ER; Wright I
    J Small Anim Pract; 2018 Jan; 59(1):50-52. PubMed ID: 29205353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat pretreatment of canine samples to evaluate efficacy of imidacloprid + moxidectin and doxycycline in heartworm treatment.
    Bendas AJR; Mendes-de-Almeida F; Von Simson C; Labarthe N
    Parasit Vectors; 2017 May; 10(1):246. PubMed ID: 28526068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
    Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J
    Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.